Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 203389 / DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 25MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| CYSTEAMINE BITARTRATE(UNII: QO84GZ3TST) (CYSTEAMINE - UNII:5UX2SD1KE2) | CYSTEAMINE | 75mg | 25mg |
Inactive Ingredients
| Ingredient Name | Raptor Therapeutics Inc. |
|---|---|
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| GELATIN, UNSPECIFIED(2G86QN327L) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A(NX76LV5T8J) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TRIETHYL CITRATE(8Z96QXD6UM) | |
| WATER(059QF0KO0R) |
LOOKING FOR A SUPPLIER?
